Concepedia

A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma

J. Gains, V. V. Moroz, Matthew Aldridge, Simon Wan, Keith Wheatley, Jennifer Laidler, Connie Peet, Jamshed Bomanji, Mark N. Gaze

European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 51 citations · 35 references

DOI

Concepts

References

35

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

, , +17

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

Susan L. Cohn, Andrew D.J. Pearson, Wendy B. London et al. · Journal of Clinical Oncology · 2008 · 1.9K citations

, , +14

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

, , +14

The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

Tom Monclair, Garrett M. Brodeur, Peter F. Ambros et al. · Journal of Clinical Oncology · 2008 · 1.1K citations · Full text

, , +12